Page last updated: 2024-08-16

temozolomide and fg-4592

temozolomide has been researched along with fg-4592 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Jin, G; Li, M; Liu, F; Su, X; Xie, Y; Zhang, J; Zhang, Q	1

Other Studies

1 other study(ies) available for temozolomide and fg-4592

Article	Year
HIF-α activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by inducing ferroptosis. Cell death & disease, 2022, 10-08, Volume: 13, Issue:10 Topics: Animals; Antineoplastic Agents; Basic Helix-Loop-Helix Transcription Factors; Cell Line, Tumor; Ferroptosis; Glioblastoma; Glycine; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Iron; Isoquinolines; Lipids; Mice; Prolyl Hydroxylases; Prolyl-Hydroxylase Inhibitors; Temozolomide	2022

Article

Year

HIF-α activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by inducing ferroptosis.

Cell death & disease, 2022, 10-08, Volume: 13, Issue:10

Topics: Animals; Antineoplastic Agents; Basic Helix-Loop-Helix Transcription Factors; Cell Line, Tumor; Ferroptosis; Glioblastoma; Glycine; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Iron; Isoquinolines; Lipids; Mice; Prolyl Hydroxylases; Prolyl-Hydroxylase Inhibitors; Temozolomide

2022